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Klebsiella pneumoniae (Kp) is an important cause of healthcare-associated infections,
which increases patient morbidity, mortality, and hospitalization costs. Gut colonization by
Kp is consistently associated with subsequent Kp disease, and patients are predominantly
infected with their colonizing strain. Our previous comparative genomics study, between dis-
ease-causing and asymptomatically colonizing Kp isolates, identified a plasmid-encoded
tellurite (TeO3
-2)-resistance (ter) operon as strongly associated with infection. However,
TeO3
-2 is extremely rare and toxic to humans. Thus, we used a multidisciplinary approach to
determine the biological link between ter and Kp infection. First, we used a genomic and bio-
informatic approach to extensively characterize Kp plasmids encoding the ter locus. These
plasmids displayed substantial variation in plasmid incompatibility type and gene content.
Moreover, the ter operon was genetically independent of other plasmid-encoded virulence
and antibiotic resistance loci, both in our original patient cohort and in a large set (n = 88) of
publicly available ter operon-encoding Kp plasmids, indicating that the ter operon is likely
playing a direct, but yet undescribed role in Kp disease. Next, we employed multiple mouse
models of infection and colonization to show that 1) the ter operon is dispensable during
bacteremia, 2) the ter operon enhances fitness in the gut, 3) this phenotype is dependent on
the colony of origin of mice, and 4) antibiotic disruption of the gut microbiota eliminates the
requirement for ter. Furthermore, using 16S rRNA gene sequencing, we show that the ter
operon enhances Kp fitness in the gut in the presence of specific indigenous microbiota,
including those predicted to produce short chain fatty acids. Finally, administration of
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exogenous short-chain fatty acids in our mouse model of colonization was sufficient to
reduce fitness of a ter mutant. These findings indicate that the ter operon, strongly associ-
ated with human infection, encodes factors that resist stress induced by the indigenous gut
microbiota during colonization. This work represents a substantial advancement in our
molecular understanding of Kp pathogenesis and gut colonization, directly relevant to Kp
disease in healthcare settings.
Author summary
The bacterial pathogen Klebsiella pneumoniae is of substantial public health concern due
to its ability to cause serious antibiotic-resistant infections. These infections frequently
occur in healthcare settings, especially in patients with detectable gut colonization by K.
pneumoniae. Importantly, infectious K. pneumoniae strains are often detected in the gut
of patients with K. pneumoniae disease, indicating that the gut is a reservoir of infectious
K. pneumoniae. Our previous work interrogating the genetic underpinnings of K. pneu-
moniae disease in colonized patients identified a strong association between K. pneumo-
niae infection and the presence of an enigmatic genetic locus known as the ter operon.
We found that this operon is not needed for pneumonia and bacteremia, and therefore,
we explored the importance of the ter operon in the gut. K. pneumoniae lacking ter func-
tion was at a disadvantage in the gut, thus explaining the connection between the ter
operon and infection in hospitalized patients. Interestingly, the advantage conferred by
the ter operon in the gut was associated with the presence of specific indigenous gut
microbiota and the presence of short-chain fatty acids, which are metabolized by the host
and gut microbiota. This work demonstrates that the ter operon is a microbiome-depen-
dent gut fitness factor and suggests that indigenous gut bacteria may limit colonization by
infectious K. pneumoniae.
Introduction
The emergence and spread of highly antibiotic-resistant bacteria have substantially compli-
cated disease treatment and control. Enterobacteriaceae are a significant contributor to the
burden of antibiotic-resistant infections through the production of extended-spectrum beta-
lactamases (ESBL-) and carbapenemases (CP-). Within the Enterobacteriaceae family is Klebsi-
ella pneumoniae (Kp), which is a substantial threat to human health, as it is the third leading
cause of all hospital-acquired infections [1,2]. Infection with ESBL- and CP-Kp is associated
with staggeringly high mortality (>50%) and excessive healthcare costs [3,4], leading the Cen-
ters for Disease Control and Prevention to categorize ESBL- and CP-Kp as serious and urgent
threats, respectively. Further complicating this issue, strains of hypervirulent Kp (hvKp) have
independently emerged in Southeast Asia. HvKp strains cause severe community-acquired
infections that are associated with mortality rates as high as 31% [5]. Furthermore, hvKp and
antibiotic-resistant strains are reported to be converging, leading to dangerous, highly antibi-
otic-resistance strains of hvKp, which have recently been detected outside of Southeast Asia
[6–9]. As these dangerous strains circulate more widely and as the number of effective treat-
ments dwindles, alternative interventions are necessary to diminish the threat posed by these
bacteria.
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Gut colonization by Kp is consistently associated with subsequent Kp disease [10–14], and
patients are predominantly infected with their colonizing strain [10,11]. However, colonizing
strains likely vary in their potential to cause infection. Variation in virulence potential is likely
mediated by the presence or absence of genes in the accessory genome of each isolate and may
be important at any step between colonization maintenance in the gut to fitness at the eventual
site of infection. As gut colonization often precedes infection [11,12], murine models of Kp
colonization are needed that are relevant to human infection. Several studies have rapidly
advanced our understanding of Kp gut colonization, including the relevance of the indigenous
gut microbiota to Kp fitness during colonization [15,16]; however, the factors underlying these
interactions remain unexplored. Importantly, previous studies have shown that gut microbiota
differs by mouse vendor and by the room within each vendor facility (referred to as “barrier”)
[17] and these differences can impact experimental output [18–20]. Therefore, any evaluation
of fitness factors during colonization should account for variations in the microbiota and how
different indigenous bacteria may interact with Kp directly or indirectly.
Comparing infected to asymptomatically colonized patients, we have previously identified
the tellurium resistance operon, known as the ter operon, as highly associated with Kp pneu-
monia and bacteremia (OR = 11.3, 95% CI = 1.6–80.0 after adjustment for clinical variables).
This enigmatic operon is found in many diverse bacteria, archaea, and some eukaryotes
wherein it bestows resistance to the toxic compound tellurite oxide (TeO3
-2) [21]. The antibac-
terial property of TeO3
-2 was first described by Sir Alexander Fleming in 1932 [22], and the
reduction of TeO3
-2 to Te0 in bacterial cells underlying that antimicrobial property was discov-
ered even earlier in 1914 [23]. Resistance to TeO3
-2 has long been used for clinical detection of
Corynebacterium diphtheriae and other pathogens [23–26]. There are several distinct genetic
loci (ter, teh, tel, kil, others) involved in TeO3-2 resistance whose gene products are predicted
to be mechanistically divergent [21,27]. Of these, the ter operon is least understood. It is highly
unlikely that the physiological function of the ter operon is to resist TeO3-2, as this compound
is exceedingly rare in the environment, and not present in humans. Previous mechanistic stud-
ies of the ter operon in non-Kp bacteria suggest a pleiotropic function, with evidence for resis-
tance to oxidative, genotoxic, heavy metal, proton motive force, cell wall, membrane, phage,
and protein synthesis stress [21,28,29], as well as a role for intracellular survival in macro-
phages [30,31]. Moreover, previous studies have suggested that the ter operon is transcription-
ally regulated by the OxyRS system [29,32], further suggesting a connection between the ter
operon and stress. Interestingly, this operon is found in several other pathogenic Enterobacter-
ales, such as Yersinia pestis, Proteus mirabilis, and enterohemorrhagic Escherichia coli
[29,31,33,34]. The association with infection, and the unique biology of TeO3
-2 and the ter
operon collectively imply that this operon is spuriously annotated based on historical in vitro
findings, warranting further investigation into its true physiological function during Kp
infection.
In Kp, the ter operon is found on pK2044-like plasmids that encode multiple virulence
genes characteristic of hypervirulent Kp strains (hvKp) [35,36]. This suggests the association
between the presence of the ter operon and Kp disease could be due to genetic linkage with
plasmid-encoded virulence genes. Moreover, the ter operon was identified as a point of recom-
bination for the Kp hypervirulence plasmid and a carbapenemase encoding plasmid [37], sug-
gesting it can both enhance fitness and enable the convergence of two worrying Kp
pathotypes. To distinguish linkage with virulence genes from an inherent function of the ter
operon in pathogenesis, we performed comparative genomic studies on a broad collection of
Kp plasmids and assessed fitness of isogenic ter mutants of a hypervirulent strain in a model of
gut colonization in two distinct microbial communities. Collectively, these data reveal that the
ter operon, highly associated with human infection, likely acts early in pathogenesis as a
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horizontally transferrable fitness factor promoting robust gut colonization in the presence of
the indigenous microbiota. Analyses of these indigenous microbiota revealed a role for short-
chain fatty acid (SCFA) metabolism in the reduction of gut fitness for Kp lacking a functional
ter operon.
Results
Characterization of the Kp ter operon
The complete ter locus consists of two distinct, but highly conserved, operons encoded on
opposite DNA strands: a set of 14 individual genes with potential biosynthetic functionality
that includes terXYW, and a tellurium resistance operon consisting of terZABCDEF (referred
to as the “ter operon”). This is followed by a predicted haloacid dehydrogenase (HAD) that is
highly conserved among ter-encoding Kp isolates (Fig 1A and S1 Table). Computational pre-
diction of protein structure and function based on amino acid sequence using I-TASSER [38–
40] indicates that many of the ter operon proteins are involved in response to stress (S1 Table),
which comports with previous studies [21]. The deletion of terC, which is predicted to be
involved in transmembrane transport (S1 Table), from the pK2044 plasmid renders hyperviru-
lent Kp strain NTUH-K2044 (clone Kp2259) exquisitely sensitive to TeO3
-2 (Fig 1B); however,
terC expressed in trans in a ΔterC strain did not restore phenotypic resistance to TeO3-2 (Fig
1B). Sequencing of a second clone (Kp2257) did not reveal any spurious mutations and dem-
onstrated insertion into the terC locus while replicating the sensitive to TeO3-2 phenotype
(S1A and S1B Fig); thus, this phenotype is attributable to insufficient terC expression from the
plasmid or polar effects of the mutation. The induction of TeO3
-2 sensitivity via polar inactiva-
tion of terDEF via mutation of terC is consistent with previous studies that demonstrate that
terBCDE are necessary for resistance to TeO3-2 [28,34]. Expression of terZ-F in trans in a ΔterC
mutant fully restored TeO3
-2 resistance (Fig 1B). Furthermore, the expression of terZ-F in
trans was sufficient to confer TeO3-2 resistance to the Escherichia coli strain MG1655 (Fig 1C).
These results indicate that an intact ter operon is necessary for TeO3-2 resistance in Kp
NTUH-K2044.
The ter operon is a genetically independent factor, rather than a biomarker
of hvKp
Next, we sought to determine if ter is genetically independent or a biomarker of hvKp, as has
been previously reported [35,36]. To this end, we returned to the ter-encoding (ter+) Kp iso-
lates from our previous study [10]. These isolates were highly diverse, as reflected by their
sequence types (Fig 2A) and none were a hvKp sequence type previously associated with the
ter operon. To determine virulence gene content, we sequenced ter-encoding plasmids from
our patient isolates using long-read sequencing (Oxford Nanopore Technologies, Oxford,
UK). ter-encoding plasmids were characteristically large (86.8–430.8 kb; S2 Fig) and some
were derived from plasmid fusions (S2 Table). These plasmids displayed substantial sequence
variation outside the ter locus (S3A and S3B Fig), indicating that the ter operon is not a marker
for a widely circulating, highly conserved, plasmid. Additionally, these ter-encoding plasmids
do not contain virulence genes associated with Kp hypervirulence, nor was a single antibiotic
resistance gene highly present on these plasmids (Fig 2B and S2 and S3 Tables). This supports
the premise that the ter operon is an independent fitness factor during infection, rather than a
marker of a hypervirulence or antibiotic resistance-encoding plasmid. Finally, predicted open
reading frames (ORFs) directly up- and downstream of the ter operon displayed minimal func-
tional conservation (Fig 2C), further indicating that this operon is not tightly linked to a
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virulence factor. Next, we repeated this analysis using publicly available reference genomes of
ter-encoding Kp isolates (n = 88). These isolates were not limited to hvKp sequence types asso-
ciated with the ter operon (Fig 2D), and indeed, the ter+ plasmids displayed a high degree of
sequence variability (S3C Fig). 42% of ter+ plasmids contained a rmpA/A2 homolog and an
accessory iron acquisition system. The remaining 58% ter+ plasmids had no classical hyper-
virulence factor present (Fig 2E and S2 and S3 Tables), and again, the predicted up- and down-
stream ORFs displayed little functional conservation except for transposase activity (Fig 2F
and S1 Table). Together, these results indicate that ter is a genetically independent factor, and
is likely playing a direct, but yet undescribed role in Kp disease.
Fig 1. The Kp terZ-F genes are sufficient for TeO3-2 resistance. (A) The ter locus is organized in two operons, a putative biosynthetic cluster and a TeO3-2
resistance cluster. These sections are found on opposite DNA strands and are encoded bidirectionally. The representative ter locus from the hvKp strain
NTUH-K2044 is shown. NTUH-K2044 containing the empty vector pACYC184, the isogenic ΔterC mutant (clone Kp2259) containing an empty vector, the pTerC,
or the pTerZ-F plasmid (B), and the E. coli K12 strain MG1655 with or without the pTerZ-F plasmid (C) were grown on LB or LB containing 10 or 100 μM K2TeO3-2
to visualize inhibition of growth (dilution series 100−10−7 of overnight culture). Two representative clones (labeled #1 and #2) of NTUH-K2044ΔterC containing the
pTerC or the pTerZ-F plasmid and MG1655 containing the pTerZ-F plasmid are shown.
https://doi.org/10.1371/journal.ppat.1009537.g001
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To determine the geographical and ecological range of Klebsiella encoding the ter operon,
14,060 Klebsiella sp. genomes, including 1,989 containing terZ-F, and their associated meta-
data were extracted from the Pathosystems Resource Integration Center (S1 Data) [41]. These
genomes were derived from Klebsiella sp. strains from 6 of 7 continents (S4A Fig), indicating a
wide geographical range that corresponds to the environmental ubiquity of Klebsiella sp.
Assessment of the specific source of Klebsiella sp. isolation indicates a wide variety of hosts,
including both animals and plants, and a number of environmental sources (S4B Fig). Interest-
ingly, we found that terZ-F containing isolates were evenly distributed amongst all isolation
sources (~14% of all isolates, S4C Fig); however, humans are the most represented isolation
source, which is not surprising given the over-representation of human isolates in bacterial
genome repositories. Many ter-containing Klebsiella sp. were isolated from human gut, blood,
and respiratory samples (S4B and S4D Fig), which both supports a role for the ter operon in
the human gut and comports with our previous studies where we originally identified a strong
association between the ter operon and infection in Kp colonized patients [10]. Overall, rela-
tively few ter-containing Klebsiella sp. isolates came from liver abscesses (S4D Fig), which are
traditionally associated with hvKp [36], although they were enriched in this infection site (S4D
Fig). Overall, ter-containing strains have a wide geographical and ecological range and are
found across multiple sites of human infection.
Fig 2. The Kp ter operon is not exclusive to hypervirulence plasmids. ter+ plasmids from Martin et al. mSystems, 2018 [10] (A-C) and reference strains from the NCBI
database (D-F) were analyzed. (A,D) Relative frequencies of sequence types (ST) of Kp strains containing ter+ plasmids. HvKp sequence types previously associated with
the ter operon are outlined in a dashed line. (B,E) Heat map of ter+ plasmid sequence similarity to genes known to influence infection and antibiotic resistance genes.
Each row represents an individual plasmid in the order of S2 Table (Martin et al. mSystems, 2018 [10] index 1–14, NCBI reference strains index 15–102). The pK2044
hvKp plasmid is highlighted by the red box, and hypervirulent Kp sequence types (hvST) previously associated with the ter operon are indicated. (C,F) To determine if any
neighboring gene was consistently associated with ter, the gene neighborhood of ter plasmids encoding the ter operon from Martin et al. mSystems, 2018 [10] was
visualized (C) and the frequency of ORFs adjacent to the ter operon encoded on reference plasmids from the NCBI database was calculated (F).
https://doi.org/10.1371/journal.ppat.1009537.g002
PLOS PATHOGENS The ter locus is a microbiome-dependent gut fitness factor
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009537 April 30, 2021 6 / 34
TerC is a microbiome-dependent gut fitness factor
We previously reported a strong association between the ter operon and Kp infection (pneu-
monia and bacteremia) in Kp colonized patients, yet also found that terC is dispensable in a
murine model of pneumonia [10]. To determine if the ter operon is important for bacteremia,
WT Kp and ΔterC were competed in a peritoneal injection model of murine bacteremia. terC
was dispensable in all tissues with the exception of a modest defect in the brain (S5 Fig). We
did not explore this finding further, as a role in meningitis would not explain the correlation
between the ter operon and infections observed in patients. We then hypothesized that the ter
operon may be required during gut colonization, which precedes infection [11,12]. Exposure
to antibiotics was not associated with Kp colonization or subsequent infection in our intensive
care unit patient population [10,42], indicating that Kp must contend with the indigenous
microbiota to colonize the gut and cause infection. Therefore, C57BL/6J mice were sourced
from two different housing sites at The Jackson Laboratory (barriers RB16 and RB07) to con-
trol for natural variations in the gut microbiota induced by housing conditions [17–20]. Mice
were orally gavaged with 100 μL of a mixture of wild-type and ΔterC Kp (Fig 3A). Intriguingly,
a fitness defect (median 5.8-, 4.7-, 8.9-, and 4.0-fold-defect on days 1–4, respectively) was
observed consistently for ΔterC in the mice sourced from RB16 over several days (Figs 3B and
S6A) but not from RB07, despite their genetic identity (Figs 3C and S6B). These data suggest
that the fitness defect exhibited by ΔterC is dependent on the gut microbiota.
To begin to characterize the effect of the indigenous microbiota on the ΔterC mutant, mice
were treated with antibiotics and the experiment was repeated. Consistent with previous stud-
ies [15], treatment with antibiotics increased overall Kp colonization density in mice from
both barriers (S6C and S6D Fig); however, this treatment also restored the fitness of ΔterC in
mice sourced from RB16 (Figs 3D and S6C). Conversely, antibiotic treatment of mice sourced
from RB07 did not impact ΔterC fitness (Figs 3E and S6D). These data indicate that an antibi-
otic-susceptible member or members of the microbiota of mice sourced from RB16 are
involved in reducing the fitness of the ΔterC mutant, as opposed to the microbiota of mice
sourced from RB07 enhancing ΔterC fitness. Furthermore, complementation of the ΔterC
mutant by expression of terZ-F in trans ameliorated its fitness defect in mice sourced from
RB16 (Fig 3F). This finding was confirmed with the fully sequenced ΔterC clone (S1C Fig). To
determine if the ter operon is required for colonization, mono-colonization studies were per-
formed. These results show that both the wild type and ΔterC mutant were able to colonize the
gut (S7 Fig), although there was mouse-to-mouse variation that may obfuscate an advantage of
the ter operon during mono-colonization. Consistent with previous studies [43–46], the mice
exhibited mortality throughout the duration of the experiment. However, the increased bacte-
rial load due to antibiotics (S6 Fig) was not associated with increased mortality, and both
strains exhibited equal virulence in this model regardless of barrier (S8 Fig). Collectively, these
data suggest that the ter operon is a microbiome-dependent gut fitness factor.
Reduced fitness of the ΔterC mutant is associated with specific gut
microbiota constituents
To determine if the composition of the gut microbiota of mice sourced from RB16 and mice
sourced from RB07 differed, we performed 16S rRNA gene sequence analysis from fecal DNA
collected throughout the course of these experiments (S9 Fig and S2 Data). To compare the
microbiota between all groups (mice sourced from RB16, RB07, RB16+Abx, RB07+Abx) and
all time points, θYC distances [47] were calculated, and principal coordinates analysis was used
to visualize these distances. θYC dissimilarity accounts for both the number of shared and
unique species as well as differential species abundance in a single metric [47]. As expected,
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microbiota differed between male and female mice (Fig 4A.i, axis 1, females cluster on left of
graph) [48–50]. Despite sex-based differences, the fecal microbiota of RB16 and RB07 were sig-
nificantly dissimilar on the day of inoculation (Fig 4A.i, axis 2, AMOVA P = 0.001; Fig 4B),
suggesting that the results observed in Fig 3B–3C were attributable to differences in the micro-
biota of these mice. In addition, the fecal microbiota of antibiotic treated mice sourced from
RB16 and RB07 were dissimilar from their untreated counterparts (Fig 4A.ii and iii, AMOVA
P< 0.001), but not from one another (Fig 4A.iv, AMOVA P = 0.676). Assessment of the mag-
nitude of dissimilarity indicated that intergroup dissimilarity was higher than intragroup dis-
similarity, and antibiotic treatment resulted in the greatest dissimilarity (Fig 4B, higher values
indicate higher dissimilarity). These findings were consistent across all time points (S10–S14
Figs). These data demonstrate an association between ter-dependent fitness in the gut and the
composition of the gut microbiota and suggest that an individual or group of gut microbiota
constituents in the mice sourced from RB16 underlies the observed loss of fitness.
There were several differences between the microbiota in mice sourced from RB16 and
RB07. The diversity of the fecal microbiota of mice sourced from RB16 was significantly higher
than mice sourced from RB07 on the day of inoculation (Fig 4C), and this difference was pres-
ent throughout the experiment (S15 Fig). We next sought to determine if a bacterial family or
families differentiated the fecal microbiota of mice sourced from RB16 and RB07 through the
use of linear discriminant analysis (LDA) effect size (LEfSe) [51]. On the day of inoculation, 7
bacterial families were found to be differentially abundant, 2 of which were more abundant in
mice sourced from RB16 and 5 of which were more abundant in mice sourced from RB07 (Fig
4D and 4E). Only unclassified Clostridiales, associated with mice sourced from RB07,
remained differential throughout the entire experiment (S16 and S17 Figs). We hypothesized
that no family consistently distinguished mice sourced from RB16 from mice sourced from
RB07 because variations in individual OTU relative abundances obscured family-level analysis.
As such, we used LEfSe to determine differentially abundant operational taxonomic units
(OTUs) between these microbiotas. On the day of inoculation, 18 OTUs were found to be dif-
ferentially abundant, 7 of which were more abundant in mice sourced from RB07, and 11 of
which were more abundant in mice sourced from RB16 (Fig 4F). Intriguingly, 4 of the 11
OTUs associated with mice sourced from RB16 had 16S rRNA sequences most similar to Mur-
ibaculum intestinale (Fig 4F; 0008, 0009, 0018, 0019) [52–54]. These 4 OTUs, as well as 0030
which had 16S rRNA sequence most similar to Clostridium scindens, remained more abundant
in mice sourced from RB16 than RB07 for the entire experiment (S18 and S19 Figs). Notably,
the Porphyromonadaceae family, of which M. intestinale was considered a member in our
dataset, was also enriched in mice sourced from RB16 on days 1–3 post-inoculation (S16 and
S17 Figs). The identification of these species as differentially abundant in mice sourced from
RB16 is notable, as M. intestinale belongs to family S24-7 which is suggested to play a role in
gut inflammatory homeostasis [20,54–57], and C. scindens has been reported to be a clinically
relevant probiotic candidate [58]. The only OTU that was more abundant in mice sourced
Fig 3. TerC is a fitness factor during gut colonization. (A) Three days prior to inoculation, male and female C57BL6/J mice
sourced from barriers RB16 and RB07 were treated with 0.5 g/L ampicillin or regular drinking water. (B-E) NTUH-K2044 and
the isogenic ΔterC mutant (clone Kp2259) were mixed 1:1 and approximately 5x106 CFU were orally gavaged into mice
(n = 9–18 per group). A fresh fecal pellet was collected daily from each animal, CFUs were enumerated, and log competitive
indices (mutant:WT) were calculated (median and IQR displayed, �P< 0.05, ��P< 0.005, ���P< 0.0005, one-sample t test
compared to a hypothetical value of 0). (F) NTUH-K2044 and the isogenic ΔterC mutant containing an empty vector or the
pTerZ-F plasmid were mixed 1:1 and approximately 5x106 CFU were orally gavaged into mice sourced from barrier RB16
(n = 14–16). A fresh fecal pellet was collected 24 hours after inoculation, CFUs were enumerated, and log competitive indices
(mutant:WT) were calculated (F, median and IQR displayed, ����P< 0.00005, one-sample t test compared to a hypothetical
value of 0 or Student’s t test). Each data point represents an individual animal.
https://doi.org/10.1371/journal.ppat.1009537.g003
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from RB07 throughout the experiment is 0037, which is most similar to Olsenella profusa (Figs
4F and S18 and S19). OTUs associated with mice sourced from RB16 by LEfSe were mostly
absent in mice sourced from RB07 (Fig 4G) throughout the course of the experiment (S18 and
S19 Figs). If these OTUs are tightly associated with the observed ΔterC mutant fitness defect,
they should also be sensitive to the antibiotic treatment that ameliorates the defect. Indeed, dif-
ferential OTUs, as well as corresponding families, were sensitive to antibiotic treatment (S20
and S21 Figs) highlighting their potential role in reducing the fitness of the ΔterC mutant.
Finally, we asked if the introduction of Kp impacted the relative abundance of these families
and OTUs. At the family level, the microbiota of mice sourced from RB16 was only minimally
modulated (S22A Fig) by Kp inoculation, and the only OTU that differentiated mice sourced
from RB16 from RB07 that was modulated was 0045 (Mordavella massiliensis, S21B Fig). Fur-
ther analysis of the gut communities of mice sourced from RB16 and RB07 demonstrated that
these communities remained stable through the course of the experiment in antibiotic-naïve
mice but shift drastically following antibiotic treatment (S22C Fig). These data indicate that
the microbiota constituents of mice sourced from RB16 reduce the fitness of the ΔterC mutant
and are highly stable during Kp colonization.
SCFA metabolism is predicted to be enriched in the gut of mice sourced
from RB16
Next, we interrogated what biological processes may result in the reduced fitness of the ΔterC
mutant. Specifically, we were interested in exploring biological processes that were characteris-
tic of the microbiota constituents of mice sourced from RB16 associated with reduced fitness
of the ΔterC mutant. To this end, the metagenomes of the fecal microbiota of mice sourced
from RB16 and RB07 were predicted using PICRUSt2 [59]. The relative abundance of pre-
dicted metabolic pathways as annotated by MetaCyc [60] differed between the fecal microbiota
of mice sourced from RB16 and RB07 (S23 Fig and S3 Data). A significant difference overall
between predicted metabolic pathways of the fecal microbiota of RB16 and RB07 was detected
on the day of inoculation and on multiple days post-inoculation although this was not readily
detected in the first two principal components that account for the majority of variation in the
data (S23 Fig). The subtlety of this finding was not surprising, as the microbiota of mice
sourced from RB16 and RB07 are distinct based on specific OTUs (Fig 4) but share a large
number of gut constituents (S9 Fig). Thus, we expected that a limited number of predicted
metabolic pathways would differentiate microbiota of mice sourced from RB16 and RB07, and
that some of these pathways would correspond to the microbiota constituents of mice sourced
from RB16 associated with the reduced the fitness of the ΔterC mutant.
LEfSe was used to determine which specific metabolic pathways differentiated the predicted
metagenomic profiles of the gut microbiota of mice sourced from RB16 and RB07 [51]. This
analysis revealed several metabolic pathways that were enriched in the gut microbiota of mice
sourced from RB16 on the day of inoculation and throughout the experiment, including gluco-
neogenesis, peptidoglycan biosynthesis, and fermentation of short-chain fatty acids (S24 and
Fig 4. The fecal microbiota in which terC is (RB16) and is not (RB07) a fitness factor are distinct. Fecal pellets collected from male and female C57BL6/J mice
sourced from barriers RB16 and RB07 (n = 9–20 mice per group) on the day of Kp inoculation were subjected to 16S rRNA sequencing. Pairwise community
dissimilarity values between the fecal microbiota communities of barriers RB16 and RB07 with or without three days treatment with 0.5 g/L ampicillin were visualized
by Principal coordinates analysis (A, AMOVA) and individually (B, ��P< 0.005, ����P< 0.00005, one-way ANOVA followed by Tukey’s multiple comparisons post-
hoc test). (C) Diversity of the fecal microbiota was summarized by inverse Simpson index (blue points: RB16+Abx, orange points: RB07+Abx, ��P< 0.005, one-way
ANOVA followed by Tukey’s multiple comparisons post-hoc test). LEfSe was used to determine if specific bacterial families (D) or OTUs (F) were differentially
abundant between the fecal microbiota of RB16 and RB07 (D, LDA� 3.5 and P< 0.05 are shown). Differential bacterial families (E) or OTUs (G) relative abundance
values were plotted (E, �P< 0.05, ��P< 0.005, ���P< 0.0005, ����P< 0.00005, Student’s t test).
https://doi.org/10.1371/journal.ppat.1009537.g004
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S25 Figs, S4 Table and S3 Data). The enrichment of SCFA metabolic pathways in the gut
microbiota of mice sourced from RB16 may be explained by the presence of M. intestinale,
which was strongly associated with the gut microbiota of mice sourced from RB16. In addition,
antibiotic treatment of mice sourced from RB16 led to a decrease in OTUs that correspond to
M. intestinale (0008, 0009, 0018, 0019), and a drastic reduction in the relative abundance of
predicted SCFA metabolic pathways (S26 Fig). This corresponds to our 16S rRNA sequencing
data, as SCFA pathways underpin the impact of M. intestinale on gut inflammatory homeosta-
sis [20,54–57].
Exogenous SCFA administration reduces the fitness of the ΔterC mutant in
the gut
SCFAs are known to have a wide variety of functions in the host, including increasing antimi-
crobial peptide production [61], intestinal epithelial barrier function [62], and acceleration of
the immune response to Enterobacteriaceae [63]. Moreover, previous studies have identified a
protective role for the SCFA acetate during Kp lung infection [64]. To determine if SCFA
metabolism is responsible for the fitness defect exhibited by ΔterC, we first explored if SCFAs
directly kill or inhibit the growth of Kp in a ter-dependent manner. Previous studies have
shown that SCFAs are able to directly inhibit the growth of Kp under acidified conditions
through disruption of respiration [65]. Thus, we grew WT Kp and ΔterC in the presence of
SCFAs (acetate, butyrate, and propionate) in both neutral and acidified conditions. Similar to
previous studies, high concentrations of SCFAs slightly inhibited growth of both strains in
neutral conditions, but completely arrested growth in acidic conditions (S27A Fig). To deter-
mine if an individual SCFA was responsible for growth inhibition, WT Kp and ΔterC was
grown in acetate, butyrate, and propionate individually and in combination in both neutral
and acidified conditions. Acetate and butyrate had the largest impacts on Kp growth; however,
growth inhibition was not dependent on the presence of terC (S27B Fig). Next, we assessed if
growth inhibition occurs in a ter-dependent manner at lower concentrations of SFCAs. Again,
titration of SCFAs in acidified media inhibited growth in a concentration-dependent manner,
but not a ter-dependent manner (S27C Fig). To determine if WT Kp are able to antagonisti-
cally inhibit the growth of ΔterC in the presence of SCFAs, competitive growth assays were
performed in the presence of SCFAs. No antagonism was observed between WT Kp and ΔterC
in the presence of SCFAs (S27D Fig). Finally, we performed killing assays with the WT Kp and
ΔterC strains to determine if SCFAs can kill Kp in a ter-dependent manner; however, no killing
was observed for either strain (S27E Fig). Collectively, these data demonstrate that SCFAs can
indeed inhibit Kp growth under acidified conditions as previously described [65], though not
in a ter-dependent manner.
To assess the effect of SCFAs on Kp gut fitness in vivo, we repeated our competitive gut col-
onization experiments with mice sourced from RB16 and RB07, but also included mice
sourced from RB07 treated continuously with a cocktail of SCFAs via drinking water. As previ-
ously observed, ΔterC Kp were less fit than WT Kp in mice sourced from RB16 but were
equally fit in mice sourced from RB07 (Fig 5). Treatment of mice from RB07 with a SCFA
cocktail led to significantly reduced fitness of the ΔterC mutant in the gut similar to that of
what was observed in RB16 (Fig 5). Finally, we measured the presence of SCFAs in the fecal
pellets of mice sourced from both barriers, as well as mice sourced from RB07 treated with
exogenous SCFAs. Fecal SCFA quantification revealed higher SCFA concentrations in the
feces of mice sourced from RB16 compared to those from RB07 (S28A Fig); however, this dif-
ference did not reach statistical significance. Treatment of mice sourced from RB16 with anti-
biotics, which restored the ΔterC fitness defect, also significantly reduced fecal SCFA levels
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(S29A Fig), specifically acetate and butyrate (S29C and S29D Fig). These data indicate that the
reduced fitness of the ΔterC mutant is due to gut SCFA levels, which is associated with differ-
ences in specific indigenous gut microbiota constituents between mice sourced from RB16
and RB07.
Discussion
The work presented here advances our understanding of Kp colonization and the transition to
infection by combining the study of both host and pathogen to describe a factor involved in
this process: the ter operon. Our previous work demonstrated a role for ter during Kp infection
[10], therefore indicating that ter is important in the infectious process. Given that prior gut
colonization often precedes disease [11–13,66], our finding that the ter operon is necessary for
gut fitness in a microbiome-dependent manner corroborates our previous studies and explains
why the ter operon is dispensable in murine models of pneumonia [10] and bacteremia but
strongly associated with human infection in these sites. The importance of the ter operon is
validated by the demonstration this operon is genetically independent, rather than a marker of
the Kp hypervirulence plasmid. Finally, we have identified a set of microbes that impact the fit-
ness of Kp strains in a ter-dependent manner, likely through SCFA metabolism. The role of ter
in resisting SCFAs is based on findings that 1) M. intestinale is a primary fermenter capable of
producing SCFAs and is uniquely present in the restrictive gut microbiota of mice sourced
Fig 5. Exogenous treatment of mice with SCFAs results in a terC fitness defect. Seven days prior to inoculation, male and female C57BL6/J
mice sourced from barriers RB16 and RB07 were treated with a SCFA cocktail or regular drinking water (sham). NTUH-K2044 and the
isogenic ΔterC mutant (clone Kp2257) were mixed 1:1 and approximately 5x106 CFU were orally gavaged into mice (n = 19 per group). A
fresh fecal pellet was collected daily from each animal, CFUs were enumerated, and log competitive indices (mutant:WT) were calculated
(median and IQR displayed, �P< 0.05, ��P< 0.005, ���P< 0.0005, one-sample t test compared to a hypothetical value of 0 or Holm-Sidak
multiple-comparison test following one-way ANOVA).
https://doi.org/10.1371/journal.ppat.1009537.g005
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from RB16 and 2) administration of SCFAs to mice sourced from RB07, which lack M. intesti-
nale, results in diminished ΔterC fitness. Moreover, the association between the antibiotic-
mediated reduction of M. intestinale from the gut of mice from RB16 and a significant reduc-
tion in fecal SCFAs support this conclusion. Collectively, these results show how a bacterial
factor can interact with its host’s microbiome to enhance colonization, which may increase
risk of infection in humans.
Gut colonization is a critical first step for many pathogens that cause both intestinal and
extra-intestinal infection. Kp, including ESBL-, CP-, and hvKp, can be isolated from multiple
sites of colonization, including the gut, nasopharynx, and skin. While skin colonization is con-
sidered a transient event [67], colonization of mucosal sites is an important event preceding
many cases of Kp disease [10–14]. Few factors have been identified that influence the transi-
tion from colonization to infection, either in a hypothesis-driven or systematic manner
[15,43,68–71]. Notably, published systematic studies rely on the administration of antibiotics
to permit gut colonization [69–71], and therein are identifying Kp gut colonization factors in
the absence of an intact microbiota. Disruption of the gut microbiome can lead to the expan-
sion of potential pathogens in the gut and increased susceptibility to infection [72–75]; how-
ever, our prior analysis of Kp colonization in over 2,400 patients found high rates of
colonization (up to 17%) but no positive association between colonization and prior antibiotic
exposure [42]. This indicates that Kp can colonize the gut in the absence of microbiome per-
turbation. Moreover, highly antibiotic-resistant bacteria have been isolated from otherwise
healthy adults [76–80], suggesting that antibiotic-resistant bacteria are also able to invade
intact microbiomes. An attractive hypothesis is that Kp circumvents microbiota-mediated col-
onization resistance by occupying newly accessible niches following antibiotic disruption of
the gut microbiome. Yet, this fails to address how Kp invades the intact gut microbiome in the
absence of antibiotic exposure. This study indicates an alternative means of circumventing
microbiota-mediated colonization resistance, wherein specific Kp factors enhance fitness dur-
ing invasion of the intact gut microbiome. In this case, the ter locus is needed for optimal fit-
ness in the presence of certain indigenous gut microbes, suggesting that acquisition of ter+
plasmids can expand the host range of a pathogen by resisting the competitive pressures of
these bacteria. This evasion of colonization resistance by horizontal gene transfer echoes the
bacterial arms race seen in response to nutritional immunity and antibiotics.
To be fit in the gut environment, Kp must overcome the stress of direct interspecies compe-
tition, nutrient limitation, and anti-microbial stress induced by the indigenous microbiota
(extensively reviewed in [81]). Kp has received increased notoriety for its ability to compete in
stressful polymicrobial environments [82–84]; however, relatively little is known about how
Kp gains an advantage over its competitors in the gut. The hvKp T6SS has been implicated in
direct interspecies competition in the gut [43], and the trehalose-6-phosphate hydrolase [45]
and cellobiose-specific PTS transporter CelB [46] have been suggested to play a role in gut
nutrient acquisition when the indigenous microbiota is present. Additionally, the Sap (Sensi-
tivity to antimicrobial peptides) transporter [85] and the acid-sensitive transcriptional regula-
tor CadC [68] are important for optimal gut fitness in the presence of the indigenous
microbiota. Our data indicates that the indigenous gut microbiota of mice sourced from RB16
create an environment that limits Kp fitness via SCFA metabolism when a functional ter
operon is absent. Notably, many of the OTUs that differentiate the gut microbiota of mice
sourced from RB16 from RB07 correspond to M. intestinale (also known as S24-7), which are
associated with increased SCFA levels [86] and known to influence gut inflammatory homeo-
stasis. Mice treated with a consortium of bacteria containing M. intestinale by oral gavage were
more resistant to Salmonella typhimurium infection in an inflammation-dependent manner
[20]. Additionally, depletion of the S24-7 family of bacteria, which includes M. intestinale,
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from the gut has been associated with lower expression of antimicrobial peptides [57],
increased inflammatory cytokines [56], and increased gut permeability [56,57]. Interestingly,
another study incidentally demonstrated an inverse relationship between family S24-7 abun-
dance and Kp gut colonization density [15]. Thus, the ter operon enhances Kp fitness, likely by
resisting stress induced by specific indigenous gut microbiota via SCFA metabolism.
The characterization of the ter operon as a microbiome-dependent gut fitness factor is of
interest, as the biology of this operon has long been enigmatic. It is possible that the ter operon
facilitates a general stress response and is not specific to TeO3
-2.The antibacterial properties of
TeO3
-2 are attributable to its ability to disrupt membrane stability and strong oxidizing action
[27,87–89]. The reduction of TeO3
-2 results in the formation of superoxides, leading to abro-
gation of DNA synthesis, protein synthesis and exhaustion of cellular reductases [90,91]. The
diversity of stress induced by TeO3
-2, in combination with corresponding studies confirming
these stresses, accounts for the pleotropic characterization of the ter operon; however, these
studies fall short of concluding that the ter operon is necessary for response to a specific physi-
ologically relevant stress. Further complicating this paradigm, other factors are often impli-
cated in the response to TeO3
-2-induced stress, such as superoxide dismutase [27] or
6-phosphogluconate dehydrogenase [92]. Studies aimed at understanding the regulation of the
ter operon have provided some insight, as they have suggested transcriptional control by OxyR
[29,32]. While these studies further connect the ter operon to oxidative stress, we were unable
to identify an OxyR binding motif in the promoter region of the Kp ter operon. The chromo-
somal location of the ter operon in these studies [29,32], as opposed to the plasmid locality in
Kp, may account for this difference. In lieu of a clear physiologically relevant stress or an obvi-
ous regulator, in silico studies have suggested the gene products of terZABCDEF form a mem-
brane-associated complex with TerC acting as the transmembrane protein ([21] and S1 Table).
This complex is thought to sense a soluble ligand or regulate membrane permeability, therein
linking the extracellular and intracellular environments [21]. Our in silico data is consistent
with many of the predicted functions of the ter operon gene products [21], and some experi-
mental evidence exists supporting the formation of a membrane-associated TerC complex
[93]. The putative biosynthetic cluster is yet more complicated and is predicted to synthesize a
nucleoside-like metabolite or potentially be involved in DNA processing [21], though it is
unclear how the TerC complex would functionally interact with this gene cluster or its prod-
ucts. In addition to TeO3
-2, ter in non-Kp species has been implicated in resistance to phage
and colicins that can be found in the gut [28], the latter being antibacterial proteins produced
by bacteria to kill their competitors [94]. It may be the case that the presence of SCFAs or
SCFA-producing bacteria create a gut environment where Kp encounters these stresses more
frequently.
Despite their simplicity, SCFAs are one of the most important gut metabolites. In the gut,
SCFAs are products of bacterial fermentation, the most common of which are acetate, buty-
rate, and propionate, which have many critical functions in colonization resistance. First, they
are able to directly inhibit bacterial growth through intracellular acidification [65,95]. We
observed a dose-dependent growth inhibition of Kp by SCFAs; however, this was independent
of the presence of a functional ter operon, suggesting that SCFAs negatively impact ΔterC fit-
ness in the gut by a different mechanism. Alternatively, the TerC protein is a predicted proton
symporter, and therein may be able to sense intracellular pH, leading to regulation of other
genes necessary for complete fitness in the gut in response to pH perturbations caused by
SCFAs that would not be observable in vitro. Regardless, SCFAs are highly plastic in their func-
tion. Second, SCFAs are important for maintaining immune homeostasis (reviewed in [96]).
This function is critical in the context of colonization resistance, as SCFAs reduce epithelial
oxygenation [97,98] and stimulate antimicrobial peptide expression in the gut [61], leading to
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reduced pathogen colonization. Interestingly, SCFAs have been shown to accelerate the
immune response to Enterobacteriaceae in the gut [63]. Interestingly, gut microbiota-influ-
enced inflammatory homeostasis has been shown to influence Kp gut colonization via IL-36
signaling though this was linked to SCFAs [16]. Notably, the SCFA that showed the largest dif-
ference between mice sourced from RB16 compared to those from RB07 was acetate. This is
notable since M. intestinale is known to produce SCFAs, and specifically acetate [55]. There-
fore, stimulation of immune pathways via microbiota derived SCFAs may reduce the fitness of
the ΔterC mutant in the gut. Alternatively, Kp strains encoding the ter operon may antagonize
Kp strains that lack the ter operon in the gut in an SCFA- or microbiome-dependent manner.
Though we explored antagonism between the WT Kp and ΔterC strains, these experiments
were performed under in vitro conditions and do not rule out the possibility of in vivo antago-
nism. Finally, SCFAs may induce production of metabolites from members of the indigenous
gut microbiota that reduce ΔterC fitness in the gut. The varied impacts of SCFAs on gut
homeostasis may explain why exogenous SCFA administration significantly reduces the fitness
of the ΔterC strain while only subtle differences in fecal SCFA concentration were observed.
Importantly, absorption and/or metabolism of these substrates by the host in the small intes-
tine, cecum, proximal colon, or by the indigenous microbiota may alter gut homeostasis while
simultaneously masking large differences in fecal SCFA concentrations [99,100]. In summary,
the ter operon represents a novel, transferrable locus that enhances fitness of Kp
NTUH-K2044 in the presence of specific gut microbiota and is associated with increased risk
of infection in hospitalized patients. Given the breadth of genetic diversity exhibited by Kp
[101], further studies with additional strains are necessary to determine the full impact of the
interaction between SCFAs and the ter operon on Kp gut fitness. As interventions that modu-
late gut homeostasis, such as fecal microbiota transplants and administration of SCFA-produc-
ing probiotic bacteria, become more common, an understanding of how pathogens are able to
overcome these barriers to colonization will be critical to ensure their success.
Methods
Ethics statement
This study was performed in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals [102]. The University of Michigan Institutional Animal
Care and Use Committee approved this research (PRO00007474).
Materials, media, and bacterial strains
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise indicated.
E. coli K12 strain MG1655, Kp strain NTUH-K2044 [103], and isogenic mutants were cultured
in Luria-Bertani (LB, Becton, Dickinson and Company, Franklin Lakes, NJ) broth at 37˚C
with shaking, or on LB agar at 27˚C (Thermo Fisher Scientific). The isogenic ΔterC mutant
was generated as previously described [10]. Briefly, the λ-red mutagenesis system was used to
inactivate the terC gene [104]. Electrocompetent NTUH-K2044 cells encoding the pKD46
plasmid were transformed with a kanamycin resistance cassette amplified from the pKD4 plas-
mid containing homologous overhangs to the terC locus. Transformed cells were recovered
overnight at 30˚ C in SOC media, then selected in the presence of 40 μg/mL kanamycin. The
isogenic ΔterC mutant was confirmed by whole-genome sequencing using the Illumina Nex-
teraXT kit on the Illumina MiSeq using a 2x250 bp V2 kit. Illumina reads are available on the
Sequence Read Archive (SRA) in BioProject PRJNA464397. To construct the pTerC and
pTerZ-F complementation plasmids, PCR products derived from WT NTUH-K2044 contain-
ing the terC or terZABCDEF open reading frames were inserted into pCR 2.1 using TOPO TA
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cloning (Life Technologies, Carlsbad, CA) and directionally ligated into pACYC184 following
digestion with Xbal and HindIII. The ligation mixture was transformed into NEB 10-beta
Competent E. coli (New England Biolabs, Ipswich, MA) by heat shock. E. coli transformants
were selected at 37˚C on LB agar containing 30 μg/ml chloramphenicol, re-cultured, and con-
firmed by colony PCR. Single transformants were then grown in batch culture for plasmid
extraction using the Plasmid Midi Kit (Qiagen, Germantown, MD). MG1655 and
NTUH-K2044 competent cells were prepared as previously described [105], electroporated
with the complementation plasmids or corresponding empty vector, and selected at 37˚C on
LB agar containing 30 (MG1655) or 80 μg/ml (NTUH-K2044) chloramphenicol. Following
selection, transformants were re-cultured, and confirmed by colony PCR and by growth in
presence of TeO3
-2. All primer sequences can be found in S5 Table. For all subsequent experi-
ments, complemented and control strains were grown in the presence of the appropriate
antibiotic.
ter+ genome identification
For plasmid analysis, ter-encoding reference strains and plasmids from the National Center
for Biotechnology Information (NCBI) nucleotide collection database were identified using
BLAST [106], wherein the entire ter locus (S3 Table) was used as the query, and Klebsiella
pneumoniae (taxid:573) as the subject (extraction date 03/27/2019). The ter operon was not
identified on any Kp chromosomes. For identification of Klebsiella sp. encoding the ter
operon, individual PATRIC Global Family annotations corresponding to the NTUH-K2044
terZABCDEF gene products were searched against the Pathosystems Resource Integration
Center (PATRIC) genome database [41]. The resulting list of genomes and corresponding
metadata (extraction date 11/16/2020) was then restricted to Klebsiella sp. and further refined
by identifying genomes that have every NTUH-K2044 terZABCDEF gene product annotation
and are of good quality as noted by PATRIC. Metadata was visualized in R (v.3.6.3) using the
“ggplot2,” “ggmap,” “maps,” and “mapdata” packages and Prism 8 (GraphPad Software, La
Jolla, CA).
Plasmid sequencing and analysis
To characterize ter-encoding Kp strains, the multi-locus sequence type (MLST) was assigned
using the Bacterial Isolate Genome Sequence Database (BIGSdb) [107,108]. To characterize
the ter-encoding plasmids from our previous study [10], genomic DNA was extracted from
pure Kp cultures using the DNeasy PowerSoil Pro Kit (Qiagen, Hilden, Germany). Long-read
genomic sequencing was performed using GridION X5 (Oxford, England) sequencing instru-
ment. Each Nanopore sequencing library was prepared using 1 μg of DNA with the 1D ligation
kit (SQK-LSK108, Oxford Nanopore Technologies) and sequenced using R9.4.1 flowcells
(FLO-MIN106). MinKNOW software was used to collect sequencing data. Nanopore reads
were called using Albacore v2.2.3 and assembled using Canu v1.7 [109]. Assemblies were cor-
rected for ten rounds with Illumina reads using Pilon v1.22 [110] in conjunction with the bow-
tie2 v2.3.3.1 aligner [111]. Assembled plasmid sequences were circularized and annotated
using Dfast [112] prokaryotic annotation pipeline. Pairwise alignments were performed using
BLAST [106]. To assess the presence of hvKp and antibiotic resistance genes, reference
sequences (S3 Table) were extracted, and BLAST [106] was used to align these reference
sequences to ter encoding plasmid sequences. To study the genes conserved around the ter
locus, gene level multiple sequence alignment (MSA) of the genes within 10 kbp upstream of
the putative biosynthetic locus and downstream of the ter operon in all the plasmids. These
loci were visualized by coding annotated genes using their 4-character gene names and
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unannotated hypothetical proteins using their gene cluster identifier as determined by
CD-HIT software [113] for the MSA. An additional MSA was performed using MAFFT [114]
in the L-INS-i mode and visualized the MSA using MSAviewer [115] to understand conserved
genes around the ter locus. To predict protein structure and function of genes within and adja-
cent to the ter locus, ter encoding plasmids were annotated using the PATRIC RAST tool kit
[116,117]. Unique annotation frequencies were calculated, and then unique predicted amino
acid sequences were annotated predictively using I-TASSER [38–40]. S1 Table indicates refer-
ence amino acid sequences used for protein structure and function prediction. Only the high-
est scoring Predicted Biological Process, Predicted Molecular Function, and Predicted
Pubchem Ligand Binding Site are reported. Finally, complete plasmid MSA was performed
and visualized using Mauve (MegAlign Pro, DNASTAR Inc., Madison, WI). Illumina and
Nanopore reads are available on the SRA in BioProject PRJNA464397.
Murine models of infection
Six- to 12-week-old C57BL/6J male and female mice from barriers RB07 and RB16 (Jackson
Laboratory, Jackson, ME) were used for all murine models of infection. Gender was evenly dis-
tributed in all groups. For bacteremia studies, WT NTUH-K2044 and NTUH-K2044ΔterC
were cultured overnight in LB, then bacteria were pelleted, resuspended, mixed 1:1, diluted in
sterile PBS to the appropriate dose, and mice were inoculated intraperitoneally with approxi-
mately 5×105 CFU in 100 μL of PBS. After 24 hours, mice were euthanized by CO2 asphyxia-
tion and blood, spleen, liver, and brain were collected. Solid organs were weighed and
homogenized in sterile PBS, and whole blood and solid organ homogenates were plated on
selective media. For oral inoculation studies, mice from both barriers were given regular
drinking water, water containing 0.5 g/L ampicillin 3 days prior to inoculation and throughout
the experiment, or water containing a SCFA cocktail (67.5 mM sodium acetate, 40 mM
sodium butyrate, 25.9 sodium propionate) 7 days prior to inoculation and throughout the
experiment. The SCFA dose and duration was chosen based on previous studies [64,118].
Antibiotic or SCFA-containing water was changed every 3 days. Kp strains were cultured over-
night in LB in the presence of antibiotics when appropriate, then bacteria were pelleted, resus-
pended, mixed 1:1, diluted in sterile PBS to the appropriate dose, and mice were orally
inoculated via oral gavage with approximately 5×106 CFU in 100 μL of PBS. Single strain infec-
tions were performed as above without mixing the two strains. For four days post-inoculation,
a fresh fecal pellet was collected from each mouse, weighed, and homogenized in sterile PBS,
and homogenates were dilution plated on both LB agar containing 10 μg/ml ampicillin or
40 μg/ml kanamycin to determine Kp load. When complemented or empty vector control
strains were used, plasmid maintenance was monitored by plating both on LB agar containing
10 μg/ml ampicillin or 40 μg/ml kanamycin to determine total Kp load, and on LB agar con-
taining 10 μg/ml ampicillin and 80 μg/ml chloramphenicol or 40 μg/ml kanamycin and 80 μg/
ml chloramphenicol to determine plasmid maintaining Kp load. In all models, mice were
monitored daily for signs of distress (hunched posture, ruffled fur, decreased mobility, and
dehydration) and euthanized at predetermined timepoints, or if signs of significant distress
were displayed. No blinding was performed between experimental groups.
16S rRNA sequencing and analysis
Fecal DNA was isolated using the MagAttract PowerMicrobiome DNA/RNA Kit (Qiagen) and
an epMotion 5075 liquid handling system. The V4 region of the 16S rRNA gene was amplified
and sequenced as previously described [119]. Standard PCRs used 1, 2 or 7 μL of undiluted
DNA and touchdown PCR used 7 μL of undiluted DNA. 16S rRNA gene sequence data was
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processed and analyzed using the software package mothur (v.1.40.2) [120,121]. Sequences
were binned into OTUs based on 97% sequence similarity using the OptiClust method [122]
following sequence processing and alignment to the SILVA reference alignment (release 128)
[123]. θYC distances [47] were calculated between communities, and AMOVA [124] was used
to determine statistically significant differences between experimental groups [47]. Principal
coordinates analysis was used to visualize the θYC distances between samples. Taxonomic com-
position of the bacterial communities was assessed by classifying sequences within mothur
using a modified version of the Ribosomal Database Project training set (version 16)
[125,126], and diversity metrics, including inverse Simpson, were calculated. Finally, linear
discriminant analysis effect size was used to determine if specific families and OTUs were dif-
ferentially abundant in different groups [51]. Putative genus and species assignments were per-
formed by comparing the representative 16S rRNA sequences from OTUs to the NCBI 16S
ribosomal RNA sequence database. These assignments were confirmed using the Ribosomal
Database Project (RDP) database, with the exception of OTUs assigned to Muribaculum intes-
tinale based on NCBI, but to Porphyromonadaceae by RDP [125]. All other assignments were
in agreement. 16S rRNA gene sequencing reads are available on the SRA in BioProject
PRJNA464397.
PICRUSt2 metagenome prediction
16S rRNA gene sequence data processed using the software package mothur (v.1.40.2)
[120,121] was used for metagenome prediction analysis using the PICRUSt2 pipeline [59]. 16S
rRNA gene sequences were aligned using HMMER (v.3.3, hmmer.org), placed in the default
16S rRNA gene reference tree, which is comprised of 20,000 16S rRNA gene sequences in the
Integrated Microbial Genomes database [127], using EPA-NG [128], and then the complete
tree was constructed with GAPPA [129]. Following tree construction, unknown lineages were
inferred, and KEGG pathway copy number was predicted using castor [130]. Finally, meta-
bolic pathway abundances were inferred from MetaCyc using MinPath [131]. For analysis,
metabolic pathway abundances were rounded to the nearest whole number and normalized
across each sample to determine the relative abundance of each gene family and inferred meta-
bolic pathway. Principle coordinate analysis was performed in R (v.3.6.3) using the “ggplot2”
and “ggfortify” packages to visualize differences in inferred metabolic pathway relative abun-
dances between experimental groups. AMOVA P values [124] were calculated using the
“vegan” package and used to determine statistically significant differences between experimen-
tal groups [47].
SCFA growth and killing assays
SCFA containing LB was prepared by adding acetic acid, butyric acid, and/or propionic acid
to LB at the appropriate concentration. The pH of SCFA-containing LB was adjusted to 7.5 or
5.75 with HCl or NaOH until the appropriate pH was achieved. Control LB lacking SCFAs was
also pH adjusted to 7.5 or 5.75. Finally, pH adjusted media was sterile filtered using a 0.22 μM
filter. For growth assays, Kp strains were cultured overnight at 37˚ C with aeration in LB in the
presence of antibiotics when appropriate. Overnight cultures were diluted to an OD600 of 0.02
in pH adjusted LB, then mixed 1:1 with pH adjusted LB with or without 2X SCFAs, to achieve
a final 1X dilution of SCFAs and OD600 of 0.01. For competitive growth assays, overnight cul-
tures were mixed 1:1 before dilution. Cultures were incubated at 37˚ C with aeration and
OD600 readings were taken every 15 min using an Eon microplate reader with Gen5 software
(Version 2.0, BioTek, Winooski, VT) for 24 hours. Area under the curve was quantified using
Prism 8 (GraphPad Software, La Jolla, CA). For killing assays, 1 mL of overnight culture was
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pelleted, resuspended in pH adjusted LB with or without SCFAs, and cultured at 37˚ C with
aeration. Cultures were sampled immediately, then every 2 hours and dilution plated on LB
agar to quantify bacterial viability.
SCFA quantification
SCFAs were quantified as previously described [86]. Briefly, archived fecal pellets were sus-
pended 1:2, 1:5, or 1:10 (weight:volume) in sterile PBS and homogenized. Homogenized sam-
ples were then centrifuged at 10,000 × g for 5 minutes to pellet the solid fraction and the
supernatant was retained. The supernatant was then vacuum through a 0 0.22 μm filter prior
to HPLC analysis. SCFA composition was measured using a Shimadzu HPLC (Shimadzu Sci-
entific Instruments) equipped with an RID-10A refractive index detector. 30 μL injections
were run on an Aminex HPX-87H column (Bio-Rad Laboratories, Hercules, CA) at 50˚ C
with 0.01 H2SO4 mobile phase and a flow rate of 0.6 mL/minute. SCFA concentration was
determined by interpolation from a 9-point standard curve containing acetate, butyrate, and
propionate at concentrations between 0.1 mM to 40 mM, then normalized to dilution factor
and tissue weight. Total SCFA concentration is a sum of acetate, butyrate, and propionate
concentrations.
Statistical analysis
For in vitro studies, two-tailed Student’s t-tests or ANOVA followed by indicated post-hoc test
was used to determine significant differences between groups. All in vitro experimental repli-
cates represent biological replicates. All animal experiments were repeated at least twice with
independent bacterial cultures. Competitive indices ((CFU mutant output/CFU WT output)/
(CFU mutant input/CFU WT input)) [132] were log transformed and a one-sample t-test was
used to determine significant differences from a hypothetical value of 0 and paired ratio t-test,
or two-tailed Student’s t-test as indicated in figure legends was used to determine significant
differences between groups. A P value of less than 0.05 was considered statistically significant
for all experiments, and analysis was performed using Prism 8 (GraphPad Software, La Jolla,
CA) unless otherwise indicated.
Supporting information
S1 Fig. Confirmation of the terC λ-red mutation. The WT NTUH-K2044 and an isogenic
ΔterC mutant clone (Kp2257) were sequenced to identify the position of the kanamycin resis-
tance cassette (“KanR”, A) and ensure that no spurious mutations occurred during the genera-
tion of this isogenic mutant. (B) NTUH-K2044 containing an empty vector and the sequenced
isogenic ΔterC mutant clone containing an empty vector or the pTerZ-F plasmid were grown
on LB or LB containing 100 μM K2TeO3-2 to visualize inhibition of growth (dilution series
100−10−6 of overnight culture). (C) NTUH-K2044 and the sequenced isogenic ΔterC mutant
clone containing an empty vector or the pTerZ-F plasmid were mixed 1:1 and approximately
5x106 CFU were orally gavaged into mice sourced from barrier RB16 (n = 6–7). A fresh fecal
pellet was collected 24 hours after inoculation, CFUs were enumerated, and log competitive
indices (mutant:WT) were calculated (median and IQR displayed, ��P < 0.005, one-sample t
test compared to a hypothetical value of 0 or Student’s t test). Each data point represents an
individual animal.
(TIF)
S2 Fig. Size of ter-encoding plasmids. The size and predicted number of coding sequences
(CDS) was determined for plasmids encoding the ter operon from Martin et al. mSystems,
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2018 (red) or reference strains from the NCBI database (blue). The pK2044 hvKp plasmid is
shown in black.
(TIF)
S3 Fig. ter-encoding plasmids display variable sequence similarity, gene arrangement and
gene content. Pairwise sequence similarities were determined for plasmids from Martin et al.
mSystems, 2018 (A), and visualized using Mauve (B). Pairwise sequence similarities were also
determined for Kp reference plasmids from the NCBI database (C). For A and C, each row
and column represent one plasmid. The Kp reference plasmid heat map is organized by pair-
wise similarity to the pK2044 hvKp plasmid.
(TIF)
S4 Fig. Klebsiella sp. containing terZ-F are distributed globally and can be found in many
different, unrelated environments. 14,060 high-quality Klebsiella sp. genomes, 1,989 of
which contain terZ-F, and their corresponding metadata were extracted from the Pathosys-
tems Resource Integration Center (PATRIC). For terZ-F containing genomes, country of isola-
tion metadata was summarized by genome counts per country (A). 665 genomes did not have
corresponding country of isolation metadata. Host species of origin metadata and correspond-
ing environment of origin metadata of terZ-F containing genomes was also summarized (B).
Klebsiella sp. isolation metadata was also compared between Klebsiella sp. genomes stratified
by the presence of the ter operon. Metadata from 10,687 human-derived, 459 non-human
derived, and 2,914 Klebsiella sp. of unknown origin isolates was compared between the source
of isolation (C). Human-derived isolates were further stratified by the site of infection, and
odds ratios were calculated between isolation site and the presence of terZ-F (D). The numbers
in parentheses indicates the total number of isolates from that site and the numbers in the heat
map boxes indicate the percent of isolates that contain or lack terZ-F at that site.
(TIF)
S5 Fig. terC is dispensable during bacteremia. NTUH-K2044 and the isogenic ΔterC mutant
(clone Kp2259) were mixed 1:1 and approximately 5x105 CFU were inoculated into male and
female C57BL6/J mice via peritoneal infection (n = 12). 24 hours post-inoculation, mice were
euthanized, tissue CFUs were enumerated (A, mean displayed, �P < 0.05, unpaired t test), and
log competitive indices (mutant:WT) were calculated (B, mean displayed, ��P < 0.005, one-
sample t test compared to a hypothetical value of 0). Each data point represents an individual
animal.
(TIF)
S6 Fig. Gut Kp load during competitive gut colonization. (A-D) Three days prior to inocula-
tion, male and female C57BL6/J mice sourced from barriers RB16 and RB07 were treated with
0.5 g/L ampicillin or regular drinking water. NTUH-K2044 and the isogenic ΔterC mutant
(clone Kp2259) were mixed 1:1 and approximately 5x106 CFU were orally gavaged into mice
(n = 9–18 per group). A fresh fecal pellet was collected daily from each animal and CFUs were
enumerated (�P < 0.05, ratio paired t test).
(TIF)
S7 Fig. terC is not a colonization factor during mono-strain gut colonization. Male and
female C57BL6/J mice sourced from barriers RB16 (A) and RB07 (B) were orally gavaged with
approximately 5x106 CFU of NTUH-K2044 or the isogenic ΔterC mutant (clone Kp2259,
n = 14–24 per group). A fresh fecal pellet was collected daily from each animal and CFUs were
enumerated (geometric mean displayed). Each data point represents an individual animal.
(TIF)
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S8 Fig. Mouse survival during gut colonization. Survival of mice from male and female
C57BL6/J barriers RB16 and RB07 (16–20 per group) following oral gavage with approxi-
mately 5x106 CFU of a 1:1 mix of NTUH-K2044 and the isogenic ΔterC mutant (clone
Kp2259, A). Survival of mice from male and female C57BL6/J barriers RB07 and RB16
(n = 14–24 per group) following oral gavage with approximately 5x106 CFU of NTUH-K2044
or the isogenic ΔterC mutant (B). Data were analyzed by Mantel-Cox test between each treat-
ment group in A and between each treatment group and between WT and ΔterC treated
groups in B.
(TIF)
S9 Fig. Community composition of mouse microbiota over time. (A-D) Fecal pellets col-
lected daily from male and female C57BL6/J mice sourced from barriers RB16 and RB07 with
or without three days treatment with 0.5 g/L ampicillin (n = 9–20 mice per group) following
Kp inoculation were subjected to 16S rRNA gene sequencing. Average relative abundance val-
ues for bacterial families where relative abundance values are greater than 0.01 are displayed.
(TIF)
S10 Fig. Differences in community composition between the microbiota of mice sourced
from barriers RB16 and RB07 remain stable over time. Fecal pellets collected daily from
male and female C57BL6/J mice sourced from barriers RB16 and RB07 (n = 16–18 mice per
group) following Kp inoculation were subjected to 16S rRNA gene sequencing. Pairwise com-
munity dissimilarity values between the fecal microbiota communities were visualized by Prin-
cipal coordinates analysis (groups compared by AMOVA). Each data point represents an
individual animal.
(TIF)
S11 Fig. Differences in community composition between the microbiota of mice sourced
from barrier RB16 with or without antibiotic treatment remain stable over time. Fecal pel-
lets collected daily from male and female C57BL6/J mice sourced from barrier RB16 with or
without three days treatment with 0.5 g/L ampicillin (n = 10–18 mice per group) following Kp
inoculation were subjected to 16S rRNA gene sequencing. Pairwise community dissimilarity
values between the fecal microbiota communities were visualized by Principal coordinates
analysis (groups compared by AMOVA). Each data point represents an individual animal.
(TIF)
S12 Fig. Differences in community composition between the microbiota of mice sourced
from barrier RB07 with or without antibiotic treatment remain stable over time. Fecal
pellets collected daily from male and female C57BL6/J mice sourced from barrier RB07
with or without three days treatment with 0.5 g/L ampicillin (n = 9–16 mice per group) follow-
ing Kp inoculation were subjected to 16S rRNA gene sequencing. Pairwise community dissim-
ilarity values between the fecal microbiota communities were visualized by Principal
coordinates analysis (groups compared by AMOVA). Each data point represents an individual
animal.
(TIF)
S13 Fig. Differences in community composition between the microbiota of mice sourced
from barriers RB16 and RB07 with antibiotic treatment remain stable over time. Fecal pel-
lets collected daily from male and female C57BL6/J mice sourced from barriers RB16 and
RB07 with three days treatment with 0.5 g/L ampicillin (n = 9–10 mice per group) following
Kp inoculation were subjected to 16S rRNA gene sequencing. Pairwise community dissimilar-
ity values between the fecal microbiota communities were visualized by Principal coordinates
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analysis (groups compared by AMOVA). Each data point represents an individual animal.
(TIF)
S14 Fig. Dissimilarity between the microbiota of mice sourced from barriers RB16 and
RB07 remains stable over time. Fecal pellets collected daily from male and female C57BL6/J
mice sourced from barriers RB16 and RB07 (n = 9–20 mice per group) following Kp inocula-
tion were subjected to 16S rRNA gene sequencing. Pairwise community dissimilarity values
between fecal microbiota communities were compared (��P< 0.005, ����P < 0.00005, one-
way ANOVA followed by Tukey’s multiple comparisons post-hoc test). Each data point repre-
sents an individual comparison.
(TIF)
S15 Fig. Differences in community diversity of mouse microbiota remain stable over time.
Fecal pellets collected daily from male and female C57BL6/J mice sourced from barriers RB16
and RB07 with or without three days treatment with 0.5 g/L ampicillin (n = 9–20 mice per
group) following Kp inoculation were subjected to 16S rRNA gene sequencing. Diversity of
the fecal microbiota was summarized by inverse Simpson index (�P< 0.05, ��P < 0.005,
����P < 0.00005, one-way ANOVA followed by Tukey’s multiple comparisons post-hoc test).
Each data point represents an individual animal. RB16 +Abx is displayed in blue, and RB07
+Abx is displayed in orange.
(TIF)
S16 Fig. Bacterial families that differentiate the microbiota of mice sourced from RB16
and RB07 over time. Fecal pellets collected daily from male and female C57BL6/J mice
sourced from barriers RB16 and RB07 (n = 16–18 mice per group) following Kp inoculation
were subjected to 16S rRNA gene sequencing. LEfSe was used to determine if specific bacterial
families were differentially abundant between the fecal microbiota of RB16 and RB07 (Families
with LDA� 3.5 and P< 0.05 are shown).
(TIF)
S17 Fig. Differences in relative abundance of bacterial families that differentiate the
microbiota of mice sourced from RB16 and RB07 over time. Fecal pellets collected daily
from male and female C57BL6/J mice sourced from barriers RB16 and RB07 (n = 16–18 mice
per group) following Kp inoculation were subjected to 16S rRNA gene sequencing. Relative
abundance of specific bacterial families that were differentially abundant between the fecal
microbiota of RB16 and RB07 by LEfSe are displayed (�P < 0.05, ��P< 0.005, ���P< 0.0005,
����P < 0.00005, Student’s t test).
(TIF)
S18 Fig. OTUs that differentiate the microbiota of mice sourced from RB16 and RB07
remain stable over time. Fecal pellets collected daily from male and female C57BL6/J mice
sourced from barriers RB16 and RB07 (n = 16–18 mice per group) following Kp inoculation
were subjected to 16S rRNA gene sequencing. LEfSe was used to determine if specific OTUs
were differentially abundant between the fecal microbiota of RB16 and RB07 (OTUs with
LDA� 3.5 and P< 0.05 are shown).
(TIF)
S19 Fig. Differences in relative abundance of OTUs that differentiate the microbiota of
mice sourced from RB16 and RB07 remain stable over time. Fecal pellets collected daily
from male and female C57BL6/J mice sourced from barriers RB16 and RB07 (n = 16–18 mice
per group) following Kp inoculation were subjected to 16S rRNA gene sequencing. Relative
abundance of specific OTUs that were differentially abundant between the fecal microbiota of
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RB16 and RB07 by LEfSe are displayed (�P< 0.05, ��P< 0.005, ���P < 0.0005,
����P < 0.00005, Student’s t test).
(TIF)
S20 Fig. Bacterial families that differentiate the microbiota of mice sourced from RB16
from RB07 are sensitive to antibiotic treatment. Fecal pellets collected daily from male and
female C57BL6/J mice sourced from barriers RB16 and RB16+Abx (n = 10–18 mice per
group) following Kp inoculation were subjected to 16S rRNA gene sequencing. Relative abun-
dance of specific bacterial families that were differentially abundant between the fecal micro-
biota of RB16 and RB07 by LEfSe are displayed (��P< 0.005, ���P < 0.0005, ����P< 0.00005,
Student’s t test).
(TIF)
S21 Fig. OTUs that differentiate the microbiota of mice sourced from RB16 from RB07
are sensitive to antibiotic treatment. Fecal pellets collected daily from male and female
C57BL6/J mice sourced from barriers RB16 and RB16+Abx (n = 10–18 mice per group) fol-
lowing Kp inoculation were subjected to 16S rRNA gene sequencing. Relative abundance of
specific OTUs that were differentially abundant between the fecal microbiota of RB16 and
RB07 by LEfSe are displayed (�P < 0.05, ��P< 0.005, ���P< 0.0005, ����P < 0.00005, Stu-
dent’s t test).
(TIF)
S22 Fig. Impact of Kp inoculation on the stability of microbiota of mice sourced from
RB16 and RB07. Family (A) and OTU (B) relative abundance values pre- (Day 0) and post-Kp
inoculation (Day 1) were subtracted to determine the impact of Kp inoculation on the fecal
microbiota communities of barriers RB16 and RB07. Only significant differential relative
abundance values are displayed (median and IQR displayed, one-sample t test compared to a
hypothetical value of 0). Each data point represents an individual animal. Community dissimi-
larity between pre- (Day 0) and post-Kp inoculation was tested by AMOVA for each day fol-
lowing Kp inoculation (C). Each cell contains the AMOVA P value for the indicated
comparison.
(TIF)
S23 Fig. Differences in PICRUSt2 metagenome metabolic pathway predictions over time.
Fecal pellets collected daily from male and female C57BL6/J mice sourced from barriers RB16
and RB07 (n = 16–18 mice per group) following Kp inoculation were subjected to 16S rRNA
gene sequencing and analyzed using PICRUSt2. Predicted metabolic pathway relative abun-
dance values were visualized by Principal coordinates analysis and dissimilarity was tested by
AMOVA. Each data point represents an individual animal.
(TIF)
S24 Fig. Short-chain fatty acid metabolic pathways differentiate the predicted metagen-
omes of the microbiota of mice sourced from RB16 and RB07 over time. Fecal pellets col-
lected daily from male and female C57BL6/J mice sourced from barriers RB16 and RB07
(n = 16–18 mice per group) following Kp inoculation were subjected to 16S rRNA gene
sequencing and analyzed using PICRUSt2. LEfSe was used to determine if predicted fermenta-
tion to short-chain fatty acid metabolic pathways were differentially abundant between the
predicted metagenome of RB16 and RB07. Note that no predicted short-chain fatty acid meta-
bolic pathways are enriched in the gut microbiota of RB07 following day 0.
(TIF)
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S25 Fig. Differences in relative abundance of predicted short-chain fatty acid metabolic
pathways that differentiate the predicted metagenomes of the microbiota of mice sourced
from RB16 and RB07 over time. Fecal pellets collected daily from male and female C57BL6/J
mice sourced from barriers RB16 and RB07 (n = 16–18 mice per group) following Kp inocula-
tion were subjected to 16S rRNA gene sequencing and analyzed using PICRUSt2. Relative
abundance of specific PICRUSt2 predicted fermentation to short-chain fatty acid pathways
that were differentially abundant between RB16 and RB07 by LEfSe are displayed (�P< 0.05,
��P< 0.005, ���P< 0.0005, ����P < 0.00005, Student’s t test).
(TIF)
S26 Fig. Antibiotic treatment reduces the relative abundance of PICRUSt2 predicted fer-
mentation to short-chain fatty acid metabolic pathways that differentiate the microbiota
of mice sourced from RB16 from RB07. Fecal pellets collected daily from male and female
C57BL6/J mice sourced from barriers RB16 with or without three days treatment with 0.5 g/L
ampicillin (n = 10–18 mice per group) following Kp inoculation were subjected to 16S rRNA
gene sequencing and analyzed using PICRUSt2. Relative abundance of specific PICRUSt2 pre-
dicted fermentation to short-chain fatty acid pathways that were differentially abundant
between RB16 and RB07 by LEfSe are displayed (�P < 0.05, ��P< 0.005, ���P< 0.0005,
����P < 0.00005, Student’s t test).
(TIF)
S27 Fig. Short-chain fatty acids (SCFAs) do not inhibit Kp growth or kill Kp in a ter-depen-
dent manner. WT NTUH-K2044 and the isogenic ΔterC mutant (clone Kp2257) were grown
in neutral (pH = 7.5) or acidic (pH = 5.75) conditions in the absence or presence of various
SCFAs in combination or individually (A-B). Area under the curve (AUC) was calculated
from growth curves (B, ����P< 0.00005 compared to no SCFA control, Tukey’s multiple com-
parison test following Two-way ANOVA, mean displayed ± SEM). WT NTUH-K2044, the iso-
genic ΔterC mutant, and the complement strain were grown in neutral (pH = 7.5) or acidic
(pH = 5.75) conditions in the presence of increasing dilutions of SCFAs, and AUC was calcu-
lated (C). To assess inter-strain antagonism in a competitive growth assay, WT NTUH-K2044
and the isogenic ΔterC mutant were mixed 1:1 at an OD600 = 0.01 and exposed to indicated
dilutions of SCFAs under acidic conditions (pH = 5.75) for 24 hours. After 24 hours, bacteria
were dilution plated on selective media and log competitive indices (mutant:WT) were calcu-
lated (D). Stationary phase WT NTUH-K2044 and the isogenic ΔterC mutant were exposed to
SCFAs under acidic conditions (pH = 5.75) to assess bacterial killing (E).
(TIF)
S28 Fig. SCFA concentrations in fecal pellets of mice sourced from RB16 from RB07 with
or without exogenous SCFA administration. Male and female C57BL6/J mice sourced from
barriers RB16 and RB07 were treated with a SCFA cocktail or regular drinking water (sham)
for 7 days. Total SCFAs (A), acetate (B), butyrate (C), and propionate (D) were quantified
from fecal pellets (mean displayed, LSD test following one-way ANOVA).
(TIF)
S29 Fig. SCFA concentrations in fecal pellets of mice sourced from RB16 with or without
antibiotic treatment. Male and female C57BL6/J mice sourced from barrier RB16 were
treated with or without antibiotics = for 3 days. Total SCFAs (A), acetate (B), butyrate (C), and
propionate (D) were quantified from fecal pellets (mean displayed, �P< 0.05, ��P< 0.005,
���P< 0.0005, Student’s t test).
(TIF)
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